Literature DB >> 35672549

Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study.

Kalendri Naidoo1,2, Montgomery Elizabeth T3, Ariana Wk Katz3, Garcia Morgan4, Reddy Krishnaveni5, Soto-Torres Lydia6, Naidoo Sarita7,8, Mansoor E Leila9.   

Abstract

The concept of efficacy, and how HIV prevention products biologically work can be complex. We report on women's interpretation of efficacy of the dapivirine vaginal ring and how they understood it to work to prevent HIV during the MTN-025/HOPE study through data collected from individual in-depth interviews. Ten women at each of the 6 HOPE research sites in Lilongwe, Malawi; Durban (2 sites) and Johannesburg, South Africa; Kampala, Uganda; and Chitungwiza, Zimbabwe, were enrolled (n = 60). Despite its partial efficacy, women trusted the ring to prevent HIV even when condoms were not used. The action of the ring was understood by most, however, there were misunderstandings around how quickly or slowly protection was offered when the ring was inserted or removed. Counselling sessions adapted to address partial efficacy, a multi-layered HIV prevention plan and how study products work could alleviate inconsistent adherence and diminished protection and further support women in receiving the best protection from their HIV prevention product of choice.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Dapivirine vaginal ring; Efficacy; HIV prevention; Ring action; Women

Year:  2022        PMID: 35672549     DOI: 10.1007/s10461-022-03745-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  3 in total

Review 1.  Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa.

Authors:  Robyn Eakle; Peter Weatherburn; Adam Bourne
Journal:  J Int AIDS Soc       Date:  2019-07       Impact factor: 5.396

Review 2.  HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.

Authors:  Connie L Celum; Sinead Delany-Moretlwe; Jared M Baeten; Ariane van der Straten; Sybil Hosek; Elizabeth A Bukusi; Margaret McConnell; Ruanne V Barnabas; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2019-07       Impact factor: 5.396

3.  Give PrEP a chance: moving on from the "risk compensation" concept.

Authors:  Daniela Rojas Castro; Rosemary M Delabre; Jean-Michel Molina
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.